Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › GnRH agonist

GnRH agonist

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of GnRH agonist

4 trials tracked of GnRH agonist: 2 in phase 3 or 4.

4Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 2 Other / NA 2
  1. Phase 3 Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Completed
  2. Phase 3 Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Completed
  3. N/A A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants Completed
  4. N/A Females, Aging, Metabolism, and Exercise Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Guideline on severe pediatric obesity with MC4R variant and puberty management
Diabetes & Endocrinology Guideline
Guideline on severe pediatric obesity with MC4R variant and puberty management Two siblings with severe obesity and early puberty found to have genetic changes affecting their growth and health over fourteen years
This guideline, based on a case report of two Chinese siblings with a heterozygous MC4R variant, synthesizes long-term management of monogen…
Two Chinese brothers with severe obesity and early puberty received special treatments for fourteen years. Their puberty slowed down, blood …
Frontiers May 2, 2026
Network meta-analysis finds GnRHa trigger reduces OHSS risk versus hCG in predicted high responders undergoing IVF
Diabetes & Endocrinology Meta-analysis
Network meta-analysis finds GnRHa trigger reduces OHSS risk versus hCG in predicted high responders undergoing IVF Study compares four IVF trigger methods for women at high risk of over-response
A network meta-analysis of 7 RCTs involving 632 predicted high responders undergoing IVF with GnRH antagonist protocols compared four final …
For women at high risk of painful IVF complications, a specific hormone trigger shot significantly lowers that risk without reducing egg cou…
Frontiers Apr 8, 2026